Global Hereditary Genetic Testing Market Report 2026–2035 Highlighting Expansion Outlook and Forecast Opportunities
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Market Size Of The Hereditary Genetic Testing Market In 2026 And What Value Is Projected For 2030?
The hereditary genetic testing market has seen rapid growth in its size over recent years. It is anticipated to expand from $23.88 billion in 2025 to $26.56 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.2%. This historical expansion can be attributed to the rising prevalence of hereditary disorders, the increasing clinical adoption of molecular diagnostics, the expansion of diagnostic laboratories, growing awareness of genetic diseases, and the availability of basic genetic testing technologies.
The hereditary genetic testing market is anticipated to experience substantial expansion in the coming years, reaching a valuation of $40.12 billion by 2030, driven by a compound annual growth rate (CAGR) of 10.9%. This projected growth can be linked to several factors, including developments in next-generation sequencing technologies, an increasing need for personalized medicine, the broader application of pharmacogenomics, greater investment in preventive healthcare, and the more extensive incorporation of genetic counseling services. Key developments expected during this timeframe involve the rising acceptance of preventive and predictive genetic tests, a greater call for early cancer risk evaluations, the proliferation of direct-to-consumer genetic testing options, the widening scope of prenatal and newborn genetic screening, and heightened public understanding of inherited cardiovascular and rare conditions.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20559&type=smp
What Drivers Are Influencing The Hereditary Genetic Testing Market?
The rising incidence of cancer is anticipated to drive the expansion of the hereditary genetic testing market in the future. Cancer encompasses a group of illnesses characterized by uncontrolled cellular proliferation capable of infiltrating or metastasizing to various bodily regions. This growing occurrence of cancer stems from elements like demographic aging, shifts in lifestyle, environmental contaminants, inherited susceptibilities, and enhanced diagnostic methods. Hereditary genetic testing aids in cancer prevention by pinpointing genetic alterations linked to heightened risk, thereby facilitating early monitoring and precise preventive approaches. For example, data from August 2024 provided by the Macmillan Cancer Support, a UK-based organization, indicated that over 3 million individuals in the UK are currently living with cancer in 2024, with projections showing this number will rise to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Consequently, the escalating incidence of cancer is fueling the expansion of the hereditary genetic testing market.
What Are The Key Segments Of The Hereditary Genetic Testing Market?
The hereditary genetic testing market covered in this report is segmented –
1) By Type: Predictive And Presymptomatic Testing, Carrier Testing, Prenatal And Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, Other Types
2) By Technology: Cytogenetic Testing, Biochemical Testing, Molecular Testing
3) By Clinical Application: Cancer Genetic Testing, Cardiovascular Genetic Testing, Neurological Genetic Testing, Rare Diseases Genetic Testing
4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Direct To Consumer (DTC) Genetic Testing Companies
Subsegments:
1) By Predictive And Presymptomatic Testing: Genetic Testing For Disease Risk Prediction, Testing For Inherited Cancer Risks, Cardiovascular Disease Risk Testing, Neurodegenerative Disease Risk Testing
2) By Carrier Testing: Testing For Inherited Genetic Disorders, Genetic Screening For Autosomal Recessive Diseases, Testing For Carrier Status Of Inherited Conditions
3) By Prenatal and Newborn Testing: Non-Invasive Prenatal Testing (NIPT), Amniocentesis and Chorionic Villus Sampling (CVS), Newborn Screening For Genetic Disorders, Preconception Genetic Screening
4) By Diagnostic Testing: Genetic Testing For Confirming Suspected Genetic Disorders, Testing For Inherited Syndromes And Congenital Diseases, Diagnostic Testing For Cancer And Tumor Profiling
5) By Pharmacogenomic Testing: Genetic Testing For Drug Response And Efficacy, Testing For Drug Sensitivities And Side Effects, Personalized Medicine And Treatment Optimization
6) By Other Types: Genetic Testing For Wellness And Lifestyle, Genetic Testing For Ancestry And Genealogy, Research-Oriented Genetic Testing
What Key Trends Are Influencing The Development Of The Hereditary Genetic Testing Market?
Major companies operating in the hereditary genetic testing market are concentrating on developing advanced genomic solutions, such as multi-cancer multigene panels, to improve early detection and individualized treatment options. Multi-cancer multigene panels function as diagnostic tests that simultaneously analyze multiple genes to identify genetic mutations linked to various types of cancer, thereby assisting in early diagnosis and personalized treatment. For example, in February 2024, Exact Sciences Corporation, a US-based provider of cancer screening and diagnostic tests, introduced the Riskguard hereditary cancer test. The Riskguard test provides a personalized report on gene-specific and familial cancer risks using a straightforward blood or saliva sample for 10 common cancers. It assists in understanding cancer risk, informing screening and treatment strategies, and evaluating family risks. Additionally, it helps to customize treatment for patients already diagnosed with cancer and enhances risk categorization for those with a family history of cancer by identifying actionable gene variants.
Who Are The Leading Companies Operating In The Hereditary Genetic Testing Market?
Major companies operating in the hereditary genetic testing market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Hologic Inc., Exact Sciences Corporation, Fulgent Genetics Inc., BioReference Laboratories Inc., BGI Group, Invitae Corporation, Color Health Inc., MedGenome Inc., Devyser AB, Mapmygenome India Ltd., Igenomix S.L.P., Myriad Genetics Inc., Natera Inc., Ambry Genetics Corporation, GeneDx LLC, Centogene N.V., CooperSurgical Inc., Sema4
Read the full hereditary genetic testing market report here:
https://www.thebusinessresearchcompany.com/report/hereditary-genetic-testing-global-market-report
Which Regions Are Expected To Experience Rapid Expansion In The Hereditary Genetic Testing Market?
North America was the largest region in the hereditary genetic testing market in 2025 and it is expected to be the fastest-growing region in the forecast period. The regions covered in the hereditary genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Hereditary Genetic Testing Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=20559&type=smp
Browse Through More Reports Similar to the Global Hereditary Genetic Testing Market 2026, By The Business Research Company
Genetically Modified Fruits Market Report 2026
https://www.thebusinessresearchcompany.com/report/genetically-modified-fruits-global-market-report
Optogenetics Market Report 2026
https://www.thebusinessresearchcompany.com/report/optogenetics-global-market-report
Genetically Modified Animal Products Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
